These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 5012479)
21. [The effects of percutaneous administration of 17 beta oestradiol in menopausal women with hyperlipidaemia (author's transl)]. Basdevant A; Guy-Grand B J Gynecol Obstet Biol Reprod (Paris); 1982; 11(2):277-80. PubMed ID: 7108161 [No Abstract] [Full Text] [Related]
22. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone]. Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629 [TBL] [Abstract][Full Text] [Related]
23. Effect of raloxifene and low-dose percutaneous 17beta-estradiol on menopause symptoms and endometrium--a randomized controlled trial. Valiati B; Capp E; Edelweiss MI; de Freitas FM; Wender MC Maturitas; 2009 Jan; 62(1):81-4. PubMed ID: 19097715 [TBL] [Abstract][Full Text] [Related]
24. [Libido loss after total surgery. Testosterone patch increases sexual desire]. Schwenkhagen A MMW Fortschr Med; 2006 Nov; 148(47):48-9. PubMed ID: 17168190 [No Abstract] [Full Text] [Related]
25. Surgical menopause, estrogen, and cognitive function in women: what do the findings tell us? Sherwin BB Ann N Y Acad Sci; 2005 Jun; 1052():3-10. PubMed ID: 16024746 [TBL] [Abstract][Full Text] [Related]
26. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder. El-Hage G; Eden JA; Manga RZ Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960 [TBL] [Abstract][Full Text] [Related]
27. [On the problem of liver tolerance of a modern estrogen preparation]. Seifert E Med Welt; 1969 Feb; 8():427-30. PubMed ID: 5771342 [No Abstract] [Full Text] [Related]
28. Effect of forebrain implants of testosterone or estradiol on scent-marking and sexual behavior in male and female rabbits. Melo AI; Chirino R; Jiménez A; Cuamatzi E; Beyer C; González-Mariscal G Horm Behav; 2008 Nov; 54(5):676-83. PubMed ID: 18706907 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacology of estrogens used in the treatment of menopause]. Basdevant A; Panotopoulos G Rev Prat; 1993 Dec; 43(20):2638-43. PubMed ID: 8146564 [TBL] [Abstract][Full Text] [Related]
30. [Estandrom. Prolonged-action oestro-androgenic combination. A balanced formula for female balance]. J Med Bord; 1966 Apr; 143(4):581-2. PubMed ID: 5933478 [No Abstract] [Full Text] [Related]
31. Testosterone "fix": youth or consequences? Should we treat "male menopause"? Utiger RD Health News; 2003 Apr; 9(4):3. PubMed ID: 12710389 [No Abstract] [Full Text] [Related]
32. [Systen--transdermal estradiol for substitution following surgical menopause]. Rachev E; Karag'ozov I Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861 [TBL] [Abstract][Full Text] [Related]
33. [The effects of hormone replacement therapy (HRT) on lipid metabolism in the menopause]. Camilli A; Di Benedetto L; Camilli FM; Ermini M Minerva Ginecol; 1997 May; 49(5):199-202. PubMed ID: 9304079 [TBL] [Abstract][Full Text] [Related]
34. Expression of prostatic glutathione-peroxidase (GSH-PO) in the rat treated with a combination of testosterone and 17beta-estradiol. Murakoshi M; Ikada R; Tagawa M Tokai J Exp Clin Med; 2003 Jul; 28(2):45-50. PubMed ID: 14714828 [TBL] [Abstract][Full Text] [Related]
35. The association of total antioxidant capacity with sex hormones. Demirbag R; Yilmaz R; Erel O Scand Cardiovasc J; 2005 Jul; 39(3):172-6. PubMed ID: 16146980 [TBL] [Abstract][Full Text] [Related]
36. [On the reactivation of atrophic oral mucosa through topical application of 17 beta-estradiol (author's transl)]. Felgentreff K; Ittrich G; Breuel H; Schubert R Zahn Mund Kieferheilkd Zentralbl; 1980; 68(2):135-9. PubMed ID: 6450496 [TBL] [Abstract][Full Text] [Related]
37. [Using pausogest for hormone replacement therapy--effect on plasma lipoproteins in menopause women]. Tsvetkov K; Monastirska M; Angelova M Akush Ginekol (Sofiia); 2008; 47 Suppl 1():29-32. PubMed ID: 18935856 [No Abstract] [Full Text] [Related]
38. [Percutaneous estrogen replacement therapy. An alternative for oral treatment]. Holst J; von Schoultz B Duodecim; 1983; 99(20):1457-62. PubMed ID: 6653450 [No Abstract] [Full Text] [Related]